Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 1
2009 1
2010 3
2011 5
2012 4
2013 2
2014 4
2015 1
2016 5
2017 8
2018 9
2019 5
2020 6
2021 8
2022 8
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Mesenchymal Stem Cell in Pancreatic Islet Transplantation.
Barachini S, Biso L, Kolachalam S, Petrini I, Maggio R, Scarselli M, Longoni B. Barachini S, et al. Among authors: petrini i. Biomedicines. 2023 May 11;11(5):1426. doi: 10.3390/biomedicines11051426. Biomedicines. 2023. PMID: 37239097 Free PMC article. Review.
Editorial: Primary and acquired resistance in lung cancer.
Bruno R, Simbolo M, Petrini I. Bruno R, et al. Among authors: petrini i. Front Oncol. 2023 Nov 1;13:1310331. doi: 10.3389/fonc.2023.1310331. eCollection 2023. Front Oncol. 2023. PMID: 38023142 Free PMC article. No abstract available.
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines.
Proto C, Manglaviti S, Lo Russo G, Musca M, Galli G, Imbimbo M, Perrino M, Cordua N, Rulli E, Ballatore Z, Maso AD, Chella A, Sbrana A, Prelaj A, Ferrara R, Occhipinti M, Brambilla M, De Toma A, Mazzeo L, Beninato T, Signorelli D, Massa G, Greco FG, Calareso G, Miliziano D, Di Mauro RM, Mella G, Lucarelli A, Paggio A, Galli F, Torri V, de Braud FGM, Pasello G, Petrini I, Berardi R, Ganzinelli M, Garassino MC, Zucali PA. Proto C, et al. Among authors: petrini i. J Thorac Oncol. 2023 Aug;18(8):1070-1081. doi: 10.1016/j.jtho.2023.04.009. Epub 2023 Apr 23. J Thorac Oncol. 2023. PMID: 37094664 Clinical Trial.
Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities.
Yamada Y, Belharazem-Vitacolonnna D, Bohnenberger H, Weiß C, Matsui N, Kriegsmann M, Kriegsmann K, Sinn P, Simon-Keller K, Hamilton G, Graeter T, Preissler G, Ott G, Schölch S, Nakajima N, Yoshizawa A, Haga H, Date H, Thomas RK, Petrini I, Giaccone G, Ströbel P, Marx A. Yamada Y, et al. Among authors: petrini i. Cell Death Dis. 2022 Nov 19;13(11):979. doi: 10.1038/s41419-022-05428-x. Cell Death Dis. 2022. PMID: 36402755 Free PMC article.
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours.
Crucitta S, Cucchiara F, Mathijssen R, Mateo J, Jager A, Joosse A, Passaro A, Attili I, Petrini I, van Schaik R, Danesi R, Del Re M. Crucitta S, et al. Among authors: petrini i. Cancer Treat Rev. 2022 Mar;104:102340. doi: 10.1016/j.ctrv.2022.102340. Epub 2022 Feb 1. Cancer Treat Rev. 2022. PMID: 35151155 Review.
74 results